StockData
Globus Medical Inc logo

Globus Medical Inc (GMED) stock

GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3044% below fair value
$69.99−0.51 (-0.72%)

Close on Nov 17, 2026Market cap $9.40BP/E 17.9Yield –

Globus Medical r&d expenses

Research and development expenses are spending on new products and technology.

Globus Medical's R&D Expenses for the twelve months ending Jun 30, 2026 was $147.06M, up 3.7% year over year. For fiscal 2025 it was $147.25M, down 10.1% from the year before. Over ten years it grew 15.0% a year on average. The highest annual figure on record is $163.75M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$147.25M-10.1%
FY2024Dec 31, 2024$163.75M+32.0%
FY2023Dec 31, 2023$124.01M+69.8%
FY2022Dec 31, 2022$73.02M-25.0%
FY2021Dec 31, 2021$97.35M+15.2%
FY2020Dec 31, 2020$84.52M+40.7%
FY2019Dec 31, 2019$60.07M+8.2%
FY2018Dec 31, 2018$55.50M+27.1%
FY2017Dec 31, 2017$43.68M-1.9%
FY2016Dec 31, 2016$44.53M+22.6%
FY2015Dec 31, 2015$36.31M+16.5%
FY2014Dec 31, 2014$31.17M+16.0%
FY2013Dec 31, 2013$26.87M-3.8%
FY2012Dec 31, 2012$27.93M+19.0%
FY2011Dec 31, 2011$23.46M+10.1%
FY2010Dec 31, 2010$21.31M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$36.32M-9.1%
Q1 FY2026Mar 31, 2026$36.51M+10.4%
Q4 FY2025Dec 31, 2025$36.16M+8.2%
Q3 FY2025Sep 30, 2025$38.07M+7.6%
Q2 FY2025Jun 30, 2025$39.95M+6.0%
Q1 FY2025Mar 31, 2025$33.06M-42.3%
Q4 FY2024Dec 31, 2024$33.41M-36.1%
Q3 FY2024Sep 30, 2024$35.38M+20.6%
Q2 FY2024Jun 30, 2024$37.70M+76.6%
Q1 FY2024Mar 31, 2024$57.27M+171.6%
Q4 FY2023Dec 31, 2023$52.25M+167.9%
Q3 FY2023Sep 30, 2023$29.33M+56.8%
Q2 FY2023Jun 30, 2023$21.35M+22.7%
Q1 FY2023Mar 31, 2023$21.08M+21.1%
Q4 FY2022Dec 31, 2022$19.51M-61.8%
Q3 FY2022Sep 30, 2022$18.70M+18.0%
Q2 FY2022Jun 30, 2022$17.40M+11.9%
Q1 FY2022Mar 31, 2022$17.41M+16.7%
Q4 FY2021Dec 31, 2021$51.02M+234.8%
Q3 FY2021Sep 30, 2021$15.85M+9.9%
Q2 FY2021Jun 30, 2021$15.55M-60.6%
Q1 FY2021Mar 31, 2021$14.92M-3.1%
Q4 FY2020Dec 31, 2020$15.24M-1.6%
Q3 FY2020Sep 30, 2020$14.42M-0.6%
Q2 FY2020Jun 30, 2020$39.46M+150.6%
Q1 FY2020Mar 31, 2020$15.40M+7.5%
Q4 FY2019Dec 31, 2019$15.50M–
Q3 FY2019Sep 30, 2019$14.51M-6.6%
Q2 FY2019Jun 30, 2019$15.75M+16.4%
Q1 FY2019Mar 31, 2019$14.32M+12.9%
Q4 FY2018Dec 31, 2018$0-100.0%
Q3 FY2018Sep 30, 2018$15.53M+42.6%
Q2 FY2018Jun 30, 2018$13.52M+26.2%
Q1 FY2018Mar 31, 2018$12.69M+19.0%
Q4 FY2017Dec 31, 2017$11.41M-16.3%
Q3 FY2017Sep 30, 2017$10.89M+6.1%
Q2 FY2017Jun 30, 2017$10.71M–
Q1 FY2017Mar 31, 2017$10.67M–
Q4 FY2016Dec 31, 2016$13.64M–
Q3 FY2016Sep 30, 2016$10.27M–

More Globus Medical figures

See a number that looks wrong?